Jim Cramer is awaiting news from GlaxoSmithKline.
20201119_THESTREETLIVE_VIDEO 3_ASTRAZENECA
The Street
Jim Cramer weighs in on the AstraZeneca vaccine candidate and current state of COVID pandemic.